Skin rash and good performance status (PS) predict improved survival with gefitinib for patients with advanced non-small cell lung cancer (NSCLC)
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. K. Mohamed, S. Ramalingam, Y. Lin, W. E. Gooding, W. Cronin, J. R. Eckardt, C. P. Belani
Institution: UPMC Hillman Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2599370508